Long-term outcomes after treatment of in-stent restenosis using the Absorb everolimus-eluting bioresorbable scaffold

QR Code

Long-term outcomes after treatment of in-stent restenosis using the Absorb everolimus-eluting bioresorbable scaffold

Saved in:

Bibliographic Details
Main Authors:	Stefan Toggweiler, Matthias Bossard, Florim Cuculi, Federico Moccetti, Mathias Wolfrum, Richard Kobza, Adrian Attinger-Toller, Mehdi Madanchi, Giacomo Maria Cioffi, Thomas Seiler, Luca Vercelli, Philipp Burkart
Format:	article
Language:	EN
Published:	BMJ Publishing Group 2021
Subjects:	Diseases of the circulatory (Cardiovascular) system RC666-701
Online Access:	https://doaj.org/article/33b409893709413c9d06b7331e6556d7
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison of the everolimus-eluting bioresorbable vascular scaffold versus the everolimus-eluting metallic stent in real-world patients with ST-segment elevation myocardial infarction
by: Piotr Desperak, et al.
Published: (2020)

Everolimus-eluting coronary stents
by: Alejandro Saez, et al.
Published: (2010)

Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds in real world patients
by: Beytullah Cakal, et al.
Published: (2020)

Everolimus-eluting stents: update on current clinical studies
by: Allocco DJ, et al.
Published: (2011)

Everolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomes
by: Panoulas VF, et al.
Published: (2015)

Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation
by: Josep Gomez‐Lara, et al.
Published: (2021)

Absorb BRS for in-stent restenosis: the final bow before (scaffold) collapse?
by: Stéphane Cook, et al.
Published: (2021)

A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease
by: Bennett J, et al.
Published: (2013)

The everolimus-eluting Xience stent in small vessel disease: bench, clinical, and pathology view
by: Sanchez OD, et al.
Published: (2014)

Computational and experimental mechanical performance of a new everolimus-eluting stent purpose-built for left main interventions
by: Saurabhi Samant, et al.
Published: (2021)

Comparison of Drug-Coated Balloon Angioplasty vs. Drug-Eluting Stent Implantation for Drug-Eluting Stent Restenosis in the Routine Clinical Practice: A Meta-Analysis of Randomized Controlled Trials
by: Yong Zhu, et al.
Published: (2021)

Novel Polymer-Free Everolimus-Eluting Stent Fabricated using Femtosecond Laser Improves Re-endothelialization and Anti-inflammation
by: In-Ho Bae, et al.
Published: (2018)

Pathological findings after third- and second-generation everolimus-eluting stent implantations in coronary arteries from autopsy cases and an atherosclerotic porcine model
by: Suguru Migita, et al.
Published: (2021)

Restenosis After Tack Implantation is Associated with Less Complex Patterns of Restenosis Compared to Stent Implantation
by: Raghu Kolluri, et al.
Published: (2020)

Pathogenesis and Clinical Significance of In-Stent Restenosis in Patients with Diabetes
by: Grzegorz K. Jakubiak, et al.
Published: (2021)

Long-term outcomes of Absorb bioresorbable vascular scaffold using predilation, sizing, and postdilation protocol in a real-world patient population
by: Sinem Çakal, et al.
Published: (2021)

Impact of anemia on in-stent restenosis after percutaneous coronary intervention
by: Huilin Hu, et al.
Published: (2021)

Factors affecting in-stent restenosis after angioplasty with the Enterprise stent for intracranial atherosclerotic diseases
by: Kun Zhang, et al.
Published: (2021)

Early scaffold strut coverage in ultra-high molecular weight amorphous PLLA sirolimus-eluting bioresorbable scaffolds: impact of strut thickness assessed in normal porcine coronary arteries
by: Paweł Gąsior, et al.
Published: (2020)

Bioresorbable scaffolds in the treatment of coronary artery disease
by: Zhang Y, et al.
Published: (2013)

Corrigendum to “A novel mechanism of inhibiting in-stent restenosis with arsenic trioxide drug-eluting stent: Enhancing contractile phenotype of vascular smooth muscle cells via YAP pathway” [Bioact. Mater. 6 2 (February 2021) 375–385]
by: Yinping Zhao, et al.
Published: (2022)

Biodegradable Cable-Tie Rapamycin-eluting Stents
by: Cheng-Hung Lee, et al.
Published: (2017)

Blood biomarkers of progressive atherosclerosis and restenosis after stenting of symptomatic intracranial artery stenosis
by: Melanie Haidegger, et al.
Published: (2021)

A better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine
by: Ikushima I, et al.
Published: (2011)

Bioresorbable vascular scaffolds technology: current use and future developments
by: Giacchi G, et al.
Published: (2016)

New drug-eluting stents: technological refinement continues
by: Javier Suárez de Lezo, et al.
Published: (2021)

A case of in stent restenosis (ISR) treated with drug-coated balloons (DCB) in a young diabetic with multiple stents
by: Tutan Das, et al.
Published: (2021)

Clonal diversity of the B cell receptor repertoire in patients with coronary in-stent restenosis and type 2 diabetes
by: Weng Ruiqiang, et al.
Published: (2021)

IN STENT RESTENOSIS (ISR) IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR CORONARY ARTERY DISEASE (CAD)
by: Waseem Raja, et al.
Published: (2020)

Iterative reconstruction improves detection of in-stent restenosis by high-pitch dual-source coronary CT angiography
by: Junjie Yang, et al.
Published: (2017)

High coronary calcium score and post-procedural CK-MB are noninvasive predictors of coronary stent restenosis
by: Lee JB, et al.
Published: (2017)

Promoting vascular healing using nanofibrous ticagrelor-eluting stents
by: Lee CH, et al.
Published: (2018)

Long-term effectiveness and safety of sirolimus drug-eluting stents
by: Bikkina M, et al.
Published: (2011)

Head-to-head comparison of sirolimus-eluting stents versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention: a meta-analysis of 76 studies.
by: Xinlin Zhang, et al.
Published: (2014)

Prophylactic paclitaxel-eluting stent placement does not improve covered femoropopliteal stent patency
by: Rory Marples, MBBS, et al.
Published: (2022)

Preclinical evaluation of sorafenib-eluting stent for suppression of human cholangiocarcinoma cells
by: Kim DH, et al.
Published: (2013)

Next generation drug-eluting stents: focus on bioabsorbable platforms and polymers
by: Brendan Doyle, et al.
Published: (2009)

Saphenous Vein Graft Aneurysm after Drug-Eluting Stent Implantation: Treatment by Covered Stent
by: Kyriacos Papadopoulos, et al.
Published: (2021)

Advances in drug eluting stents &ndash; focus on the Endeavor&reg; zotarolimus stent
by: Jonathan Bridges, et al.
Published: (2008)

Optical computed tomography (OCT) guided follow up of primary PCI patients for predicting factors for restenosis and late stent malapposition
by: Swati Sharma, et al.
Published: (2021)